nach oben

Langenbeck's Archives of Surgery

Erschienen in:

01.04.2004 | Original Article

Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer?

Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication

verfasst von: K. Hamaguchi, K. Ogawa, T. Katsube, S. Konno, M. Aiba

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

After partial gastrectomy, the mucosa of the residual stomach usually undergoes severe changes, and these lesions are known to be pre-cancerous. Recently, Helicobacter pylori has been highlighted as an agent that induces such mucosal alterations. In the present study, we evaluated whether eradication of H. pylori reduced the risk of carcinogenesis.

Patients and methods

The subjects were 12 patients who underwent distal gastrectomy with Billroth I anastomosis for early gastric cancer and were positive for H. pylori. We performed endoscopy and biopsy both before and after H. pylori eradication therapy to assess changes in the gastric mucosa.

Results

After eradication therapy, no mucosal edema or erythema was detected. On histological examination, mononuclear cell infiltration had decreased and there was complete absence of neutrophil infiltration. The Ki-67 labeling index and the tissue IL-8 level had also decreased significantly, compared with before eradication.

Conclusion

Before H. pylori eradication, the mucosa of the residual stomach may be at high risk of carcinogenesis due to induction of mucosal damage and active gastritis by H. pylori. Such changes were almost completely normalized by eradication therapy, so the eradication of H. pylori may reduce the risk of H. pylori-associated carcinogenesis in patients who have undergone gastrectomy for early gastric cancer.

Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131PubMed

Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perz GI, Blaser MJ (1991) Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132–1136PubMed

Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, Kato T, Tatsuta M, Graham DY (1994) Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 73:2691–2694PubMed

Fukuda H, Saito D, Hayashi S, Hisai H, Ono H, Yoshida S, Oguro Y, Noda T, Sato T, Katoh M, Terada M, Sugimura T (1995) Helicobacter pylori Infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 86:64–71PubMed

Kikuchi S, Wada O, Nakajima T, Nishi T, Kobayashi O, Konishi T, Inaba Y and the research group on prevention of gastric carcinoma among young adults (1995) Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 75:2789–2793PubMed

International Agency for Research on Cancer (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. IARC Scientific Publication no 61, Lyon, pp 177–240

Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G (1997) Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6:639–642PubMed

The European Helicobacter pylori study group (1997) Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 41:8–13PubMed

Langhans P, Bues M, Bunte H (1984) Morphological changes in the operated stomach under the influence of duodenogastric reflux. Clinical follow-up over 20 years. Scand J Gastroenterol 19 [Suppl 92]:145–148

10.

Weinstein WM, Buch KL, Elashoff J, Reedy T, Tedesco FJ, Samloff IM, Ippoliti AF (1985) The histology of the stomach in symptomatic patients after gastric surgery: a model to assess selective patterns of gastric mucosal injury. Scand J Gastroenterol 20 [Suppl 109]:77–89

11.

Domellof L (1979) Gastric carcinoma promoted by alkaline reflux gastritis—with special reference to bile and other surfactants as promoters of post-operative gastric cancer. Med Hypotheses 554:63–76

12.

Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process—first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 52: 6735–6740PubMed

13.

Safatle-Ribeilo AV, Ribeilo U Jr, Clarke MR, Sakai P, Ishioka S, Garido AB Jr, Gama-Rodrigues J, Safatle NF, Reynolds JC (1999) Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation following partial gastrectomy. Dig Dis Sci 2:243–252CrossRef

14.

Kurihara N, Kubota T, Ohtani Y, Kumai K, Kitazima M (1995) High incidence of Helicobacter pylori infection detected serologically in the residual stomach by gastric cancer. Oncol Rep 4:103–106

15.

Katsube T, Ogawa K, Hamaguchi K, Murayama M, Konno S, Shimakawa T, Naritaka Y, Yagaw H, Kajiwara T, Aiba M (2002) Prevalence of Helicobacter pylori in the residual stomach after gastrectomy for gastric cancer. Hepatogastroenterology 49:128–132PubMed

16.

Hiker E, Domske W, Stoll R (1996)¹³C-urea breath test for detection of Helicobacter pylori and its correlation with endoscopic and histologic findings. J Physiol Pharmacol 47:79–90PubMed

17.

Yamamoto Y, Kouda M, Abe K. Sakurabayashi S, Sezai S, Hirano M, Oka H (1995) Detection of Helicobacter pylori by culture and the ¹³C-urea breath test using an automated breath ¹³C analyzer. JSGE 92:1839–1845

18.

Graham PD, Klein PD, Evance DJ Evance DG, Alpert LC, Opekum AR, Boutton TW (1987) Campylobacter pylori detected noninvasively by the ¹³C-urea breath test. Lancet i:1174–1177CrossRef

19.

Klein PD, Malaty HM, Martin RF, Graham KS, Genta RM, Graham DY (1996) Noninvasive detection of Helicobacter pylori infection in clinical practice: the ¹³C-urea breath test. Am J Gastroenterol 91:690–694PubMed

20.

Ohara S, Kato M, Asaka M, Toyota T (1998) Studies of ¹³C-urea breath test for diagnosis of Helicobacter pylori infection in Japan. J Gastroenterol 33:6–13

21.

Lotterler E, Ludtke FE, Tegeler R, Lepsien G, Bauer FE (1993) The ¹³C-urea breath test-detection of Helicobacter pylori infection in patients with partial gastrectomy. Z Gastroenterol 31:115–119

22.

American Digestive Health Foundation (1997) The report of the digestive health initiative international update conference on Helicobacter pylori. Gastroenterology 113:4–8

23.

Tytgat GNJ (1991) The Sydney system: endoscopic division. Endoscopic appearance in gastritis/duodenitis. J Gastroenterol Hepatol 6:223–234PubMed

24.

Dixson MF, Genta RM, Yardley JH, Crrea P (1996) Classification and grading of gastritis. The update Sydney system. Am J Surg Pathol 20:1161–1181CrossRefPubMed

25.

Bradford MA (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–254CrossRefPubMed

26.

Endo I, Sugiyama M, Yamamoto T, Katamura H (1992) The role of Helicobacter pylori on gastritis occurring in the gastric stump. Ther Res 13:2653–2656

27.

Kiyozaki H, Nei J, Hayase M (1993) The role of Helicobacter pylori in gastritis after distal partial gastrectomy. Gastroenterol Endosc 35:9–14

28.

Nagahata Y, Kawakita N, Azumi Y, Numata N, Yano M, Saitoh Y (1996) Etiological involvement of Helicobacter pylori in reflux gastritis after gastrectomy. Am J Gastroenterol 91:2130–2134PubMed

29.

Kurihara N, Kubota T, Hayashi N, Ishizuka H, Hoshiya Y, Sakurai Y, Yoshida M, Murayama Y, Ohtani Y, Kumai H, Kitazima M (1995) Gastritis in the residual stomach and Helicobacter pylori infection. Gastroenterol Endosc 37:2441–2445

30.

Leivonen MK, Haglund CH, Nordling SFA (1997) Helicobacter pylori infection after partial gastrectomy for peptic ulcer and its role in relapsing disease. Eur J Gastroenterol Hepatol 9:371–374PubMed

31.

Miwa H, Hirose M, Kikuchi S, Terai T, Iwazaki R, Kobayashi O, Takei Y, Ogihara T, Sato N (1999) How useful is the detection kit for antibody in urine (URINELISA) in clinical practice? Am J Gastroenterol 94:3460–3463CrossRefPubMed

32.

Buruk F, Berberoglu U, Pak I, Aksaz E, Celen O (1993) Gastric cancer and Helicobacter pylori infection. Br J Surg 80:378–379PubMed

33.

Sipponen P, Seppala K (1992) Gastric carcinoma: failed adaptation to Helicobacter pylori. Scand J Gastroenterol 27:33–38PubMed

34.

Sipponen P, Hyvarinen H (1993) Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 28:3–6

35.

Correa P, Ruiz B, Shi TY, Janney A, Sobhan M, Torrado J, et al (1994) Helicobacter pylori and nucleolar organizer regions in the gastric antral mucosa. Am J Clin Pathol 101:656–660PubMed

36.

Fan XG, Kelleher D, Fan XL, Xia HX, Keeling PWN (1996) Helicobacter pylori increases proliferation of gastric epithelial cells. Gut 38:19–22PubMed

37.

Hibi K, Mitomi H, Koizumi W, Tanabe S, Saigenji K, Okayasu I (1997) Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 108:26–34PubMed

38.

Lynch DAF, Mapstone NP, Clarke AMT, Jackson P, Dixon MF, Quirke P (1995) Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut 36:351–353PubMed

39.

Leivonen M, Nordling S, Haglund C(1997) Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types? Anticancer Res 17:3893–3896PubMed

40.

Blaser MJ (1992) Hypotheses on the pathogenesis and natural history of Helicobacter pylori -induced inflammation. Gastroenterology 102:720–727PubMed

41.

Cover TL, Blaser MJ (1992) Helicobacter pylori and gastroduodenal disease. Annu Rev Med 43:135–145CrossRefPubMed

42.

Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045–1049PubMed

43.

Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K (1991) Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol 9:617–648PubMed

44.

Davies GR, Banatvala N, Collins CE, Sheaff MT, Abdi Y, Clements L, Rampton DS (1994) Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 29:419–424PubMed

45.

Ohkusa T, Kumagai J, Tanizawa T (1998) Changes in endoscopic features of H. pylori-related gastritis with follow-up over a year after eradication of H. pylori, measured according to the Sydney system. Gastroenterol Endosc 10:1001–1008

46.

Kawakita N, Nagahata Y, Azumi Y, Wada T, Numata N, Saitoh Y (1995) Residual gastritis after gastrectomy and Helicobacter pylori—Its clinical significance. Jpn J Gastroenterol 92:862–869

47.

Rauws EJ, Langenberg W, Houthoff HJ, Zanen HC, Tygat GN (1988) Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33–40PubMed

48.

Murakami K, Fujioka T, Kodama R, Kubota T, Tokieda M, Nasu M (1997) Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. J Gastroenterol 32:184–188PubMed

49.

Shijou Y (1998) Gastric epithelial cell proliferation before and after eradication therapy of Helicobacter pylori. An immunohistochemical study. J Tokyo Women Med Univ 68:123–130

50.

Brenes F, Ruiz B, Correa P, Hunter F, Rhamakrishnan T, Fontham E, Shi TY (1993) Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 88:1870–1875PubMed

51.

Zang QB, Dawodu JB, Husain A, Etohli G, Gemmell CG, Russell RI (1997) Association of antral mucosal levels of interleukin-8 and reactive oxygen radicals in patients infected with Helicobacter pylori. Clin Sci 92:69–73PubMed

52.

Ito M, Haruma K, Kamada T, Mihara M, Kim S, KItadai Y, Sumii M, Tanaka S, Yoshihara M, Chayama K (2002) Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Alimental Pharmacol Ther 16:1449–1456CrossRef

53.

Nordone G, Staibano S, Rocco A, Mezza E, D’Armiento FP, Insabato L, Coppola A, Salvatore G, Lucariello A, Fugura N, De Rosa G, Budillon G (1999) Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 44:789–799PubMed

54.

Murakami K, Fujioka T, Okimoto T, Mitsuishi Y, Oda T, Nishizono A, Nasu M (1999) Analysis of p53 gene mutations in Helicobacter pylori -associated gastritis mucosa in endoscopic biopsy specimens. Scand J Gastroenterol 34:474–477CrossRefPubMed

Titel: Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer?
Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication
verfasst von: K. Hamaguchi
K. Ogawa
T. Katsube
S. Konno
M. Aiba
Publikationsdatum: 01.04.2004
Verlag: Springer-Verlag
Erschienen in: Langenbeck's Archives of Surgery / Ausgabe 2/2004
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-003-0451-x

Neu im Fachgebiet Chirurgie

Gegen postoperative Darmmotilitätsstörung: Erster Kaffee schon im Aufwachraum

30.04.2024 DCK 2024 Kongressbericht

Nach einer Operation kann es zu einer vorübergehenden Störung der Darmmotilität kommen, ohne dass es eine mechanische Ursache gibt. Auf eine postoperative Darmmotilitätsstörung weist besonders hin, wenn Nahrung oral nicht toleriert wird.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background and aims

Patients and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2004

Checking for interviewer bias in outcome assessment: a method for strengthening the design of prospective, randomised trials in surgery

Liver transplantation for hepatocellular carcinoma: a single European centre experience

Professor Dr. med. Dr. med. h. c. Walter Brendel 1922–1989

Prognostic significance of the location of intramural metastasis in patients with esophageal squamous cell carcinoma

Survival after surgical treatment of breast cancer

Survival after surgical treatment of early gastric cancer: surgical techniques and long-term survival

Update Chirurgie